Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A9MY
|
|||
Former ID |
DNC010578
|
|||
Drug Name |
N-(6-(4-aminophenyl)-1H-indazol-3-yl)butyramide
|
|||
Synonyms |
CHEMBL1086638; N-[6-(4-aminophenyl)-1H-indazol-3-yl]butanamide; N-(6-(4-aminophenyl)-1H-indazol-3-yl)butyramide; SCHEMBL6478145; DCCRABAZYMVLJU-UHFFFAOYSA-N
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H18N4O
|
|||
Canonical SMILES |
CCCC(=O)NC1=NNC2=C1C=CC(=C2)C3=CC=C(C=C3)N
|
|||
InChI |
1S/C17H18N4O/c1-2-3-16(22)19-17-14-9-6-12(10-15(14)20-21-17)11-4-7-13(18)8-5-11/h4-10H,2-3,18H2,1H3,(H2,19,20,21,22)
|
|||
InChIKey |
DCCRABAZYMVLJU-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Rational design of potent GSK3beta inhibitors with selectivity for Cdk1 and Cdk2. Bioorg Med Chem Lett. 2010 Mar 15;20(6):1985-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.